US Patent Issued to 1ST Biotherapeutics on Dec. 30 for "[ 18 F-labeled imidazopyridine derivatives as PET radiotracer" (South Korean Inventors)

ALEXANDRIA, Va., Dec. 31 -- United States Patent no. 12,509,458, issued on Dec. 30, was assigned to 1ST Biotherapeutics Inc. (Gyeonggi-do, South Korea).

"[ 18 F-labeled imidazopyridine derivatives as PET radiotracer" was invented by Jinhwa Lee (Gyeonggi-do, South Korea) and Hwajung Nam (Busan, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to [18F]-labeled imidazopyridine derivatives or salts thereof as positron emission tomography (PET) radiotracers suitable for imaging the stress-signaling non-receptor tyrosine kinase c-abl, and their use in in vivo diagnosis, preclinical and clinical imaging, patient stratification on the basis of mutational status of c-abl and a...